Clinical Trial Update: Effect of Weight on the Population Pharmacokinetic Analysis of Doxorubicin and Cyclophosphamide [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update examining how weight affects population pharmacokinetics of doxorubicin and cyclophosphamide in breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)

Snippet

Sponsor: Texas Tech University Health Sciences Center | Conditions: Breast Cancer, Obesity | Phase 4 | Status: COMPLETED | Results posted: 2018-08-22